|
 |
NutropinThis page contains recent news articles, when available, and an overview of Nutropin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Nutropin (when available) Used in the treatment of dwarfism and growth failure, growth hormone (hGH) stimulates skeletal growth in pediatric patients with growth failure due to a lack of adequate secretion of endogenous GH. Skeletal growth is accomplished at the epiphyseal plates at the ends of a growing bone. Growth and metabolism of epiphyseal plate cells are directly stimulated by GH and one of its mediators, IGF-I (insulin-like growth factor). For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss Mechanism Of Action: hGH binds to the human growth hormone receptor (GHR). Upon binding, hGH causes dimerization of GHR, activation of the GHR-associated JAK2 tyrosine kinase, and tyrosyl phosphorylation of both JAK2 and GHR. These events recruit and/or activate a variety of signaling molecules, including MAP kinases, insulin receptor substrates, phosphatidylinositol 3' phosphate kinase, diacylglycerol, protein kinase C, intracellular calcium, and Stat transcription factors. These signaling molecules contribute to the GH-induced changes in enzymatic activity, transport function, and gene expression that ultimately culminate in changes in growth and metabolism. News Articles on Somatropin recombinant Tiger Woods not part of investigation of physician - Dec 18, 2009 US Customs&Border Protection officers reported that, among the items found in her car were a quantity of Nutropin, a human growth hormone that is sometimes ... Buffalo News Drug doc denies Tiger angle - Dec 19, 2009 28, is... criminally with conspiring with his assistant Mary Anne Catalano, 32, to smuggle Actovegin and Nutropin into the US between Jan. ... Toronto Sun Two Stories - Dec 30, 2009 The Royal Canadian Mounted Police have already... him with conspiring to smuggle Nutropin (a human growth hormone) and other drugs into the United ... San Diego Reader Ex-Galea assistant 'just doing her job' transporting drugs: Lawyer - Dec 17, 2009 ...found inside “20 vials, 101 syringes, and 76 ampoules, of unknown misbranded drugs, including Nutropin, a medical centrifuge and an ultrasound computer. ... Toronto Sun Roche opens US$500m manufacturing facility in Singapore - Nov 3, 2009 ..."This plant was designed for the E.coli or bacterial fermentation platform, but we can produce products like Nutropin, a growth hormone, here. ... Channel News Asia Biotech firm gets rights to drug Genentech buying technology for new ... - Dec 21, 2006 Nutropin, which Genentech sells only in the United States, ... Nutropin was the best-selling growth hormone in the United States last year. ... San Francisco Chronicle Genentech, Tercica sign growth hormone drug deal - Jul 10, 2007 Tercica will fund and lead the development of two products that combine Genentech's human growth hormone Nutropin and Tercica's insulin-like growth factor ... Reuters Tercica Reports Fourth Quarter and Year-End 2007 Financial Results - Feb 27, 2008 The goal of the study is to provide a majority of patients with a co-mixture of Nutropin AQ® and Increlex® administered as single injection. ... Lifescience-online Genentech's Potter to Serve as Consultant - Aug 16, 2005 Potter joined Genentech in 2000 as executive vice president and chief operating officer and oversaw the launch of Avastin, Raptiva, Xolair, Nutropin AQ Pen, ... TheStreet.com - TheStreet.com (subscription) Genentech Stretches Nutropin Markets With New Approvals - Jul 8, 2005 By Aaron Lorenzo. Genentech Inc. got the green light to expand its growth hormone market, as the FDA approved Nutropin (somatropin [rDNA origin] for ... BioWorld Online - BioWorld Online FDA Safety Labeling Changes: Activella, Duramorph PF, Nutropin - Sep 7, 2005 Sept. 7, 2005 — The US Food and Drug Administration (FDA) approved in June revisions to safety labeling to advise that use of estradiol/norethindrone ... Medscape Tercica, Genentech Sign Combo HGH/IGF-1 Product Partnership - Jul 12, 2007 The Nutropin/Increlex combination drug "could prove superior to Increlex" in ISS. The AGHD market is smaller, though Tercica estimated that the worldwide ... BioWorld Online - BioWorld Online Genentech stretches nutropin markets.(Friday, July 8)(Genentech... - Jul 11, 2005 Genentech Inc. got the green light to expand its growth hormone market, as the FDA approved Nutropin (somatropin [rDNA origin] for injection) and Nutropin ... Pay-Per-View - BioWorld Week - Factiva, from Dow Jones Loislaw Federal District Court Opinions - ALLEN v. CRYSTALCOAST, INC … - May 11, 2007 Nutropin is manufactured by Genentech (former defendant). In 2000, Willie's parents received Nutropin first from Coram Prescription Services, Inc., ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Genentech and Ipsen Agree to Develop Sustained-Release Formulations … - Mar 21, 2005 Nutropin AQ Pen(R) for use with the Nutropin AQ Pen(R) cartridge was cleared for ... Nutropin AQ is supplied as 10 mg of sterile liquid somatropin per ... RedOrbit FDA Approves a Generic Biodrug - Jun 1, 2006 The drug, a version of Nutropin from Genentech and Genotropin from Pfizer, is a protein used to treat growth deficiencies in children and adults, ... New York Times Article: Resins.(New Products)(Buyers Guide) - JCT CoatingsTech | … - Jun 1, 2005 Article: FDA APPROVES NUTROPIN AQ PEN FOR DELIVERY OF GROWTH ... ... South San Francisco, has announced that the Nutropin AQ Pen(TM) has received clearance ... Pay-Per-View - JCT CoatingsTech - HighBeam Research Press Release: Orexigen Announces Initiation of Phase III Clinical... - May 22, 2007 14 June 1999-GENETECH: Phase III clinical trial shows promising results of Nutropin ... announced positive results of a Phase III multi-center trial of ... Pay-Per-View - M2 Presswire - HighBeam Research Collaborations; Companies to develop sustained-release formulations... - Apr 18, 2005 Nutropin AQ Pen for use with the Nutropin AQ Pen cartridge was cleared for marketing ... Nutropin AQ is supplied as 10 mg of sterile liquid somatropin per ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Company Profile Report - Oct 11, 2008 In January 2008, the Company initiated dosing of patients with Nutropin AQ and ... Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) ... $50.00 - Revere Reports - Revere Collaborations; Companies to develop sustained-release formulations... - Apr 22, 2005 Nutropin AQ Pen for use with the Nutropin AQ Pen cartridge was cleared for marketing ... Nutropin AQ is supplied as 10 mg of sterile liquid somatropin per ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones Merger and Acquisition Scenario - Aug 19, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Company Profile Report - Oct 11, 2008 In January 2008, the Company initiated dosing of patients with Nutropin AQ and ... Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) ... $50.00 - Revere - Alacra Store Collaborations; Companies to develop sustained-release formulations... - Apr 19, 2005 Nutropin AQ Pen for use with the Nutropin AQ Pen cartridge was cleared for marketing ... Nutropin AQ is supplied as 10 mg of sterile liquid somatropin per ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Merger and Acquisition Scenario - Apr 15, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 13, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 19, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 11, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Best use of direct marketing to consumers.(Direct Marketing) - Nov 1, 2007 The objective of this campaign was to enroll 25% of identified Nutropin patients in the US ... Nutropin is a growth hormone therapy indicated for a range of ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com Merger and Acquisition Scenario - Aug 19, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Press Release: QualityStocks News - Nuvelo, Inc. (NUVO) Trades Higher... - Dec 12, 2008 M2 Presswire; October 23, 1998 ; 700+ words ... ... positive preliminary results of Phase III clinical trial of Nutropin Depot (C)1994-98 M2 ... completion ... Pay-Per-View - M2 Presswire - HighBeam Research Loislaw Federal District Court Opinions - SOTO v. GENENTECH, INC. ( … - Oct 17, 2008 In that capacity, Mr. Soto was responsible for selling the growth hormone drug Nutropin, in the Southern Florida territory. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Press Release: Examine the Changing Dynamics Prevelant in the US … - Sep 16, 2008 Article: US FDA: FDA approves Nutropin Depot, first lo long-acting dosage ... ... Nutropin Depot is a long-acting form of Genentech's human growth hormone ... Pay-Per-View - M2 Presswire - HighBeam Research Biotech Tercica rides a wave of new drugs - Sep 21, 2007 That last potential Increlex-Nutropin combo could deepen Tercica's product pipeline significantly. It could eventually be used to treat diseases such as ... Bizjournals.com Press Release: New Report Contains In-depth Analysis of Phase II and... - Feb 1, 2008 M2 Presswire; October 23, 1998 ; 700+ words ... ... positive preliminary results of Phase III clinical trial of Nutropin Depot (C)1994 ... completion of a ... Pay-Per-View - M2 Presswire - HighBeam Research Biomarker group grows - Sep 3, 2007 For Genentech, a new product could increase its revenue stream for Nutropin and stave off competition in the crowded growth-hormone market—now standing at ... Nature.com My, How You've Grown - Nov 28, 2005 Now Genentech can also market Nutropin to children, like Angelo, with idiopathic short stature (ISS), meaning they're short for no obvious medical reason. ... BusinessWeek Competitors by Product Report - Oct 11, 2008 In January 2008, the Company initiated dosing of patients with Nutropin AQ and ... Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) ... $75.00 - Revere - Alacra Store Great heights for short kids - Aug 20, 2006 California-based Genentech received similar approval in 2005 for its drug Nutropin. Caption text only. Say your son or daughter is short. ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Drug/Medical Device Report Tercica, Inc. (TRCA) - Oct 11, 2008 Genentech, Inc. (DNA) / Nutropin/Nutropin AQ. (Recombinant Somatropin (Human Growth ... Origin)/Nutropin AQ (Somatropin rDNA. Origin) Combination Products ... $70.00 - Revere Reports - Revere Article: Recent campaigns focus on education.(LANDMARK CAMPAIGNS … - Oct 1, 2006 Nutropin Nutropin Stepping Stones Patient Support The objective of this campaign ... Nutropin Stepping Stones Patient Support * Euro RSCG Life Metamax and . ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Competitors by Product Report - Oct 11, 2008 In January 2008, the Company initiated dosing of patients with Nutropin AQ and ... Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) ... $75.00 - Revere Reports - Revere Alkermes Reports Financial Results for Fiscal Year 2005 and Provides ... - May 19, 2005 Cost of goods manufactured was $16.8 million in fiscal 2005, consisting of approximately $14.5 million for Risperdal Consta and $2.3 million for Nutropin ... $4.95 - Business Wire - ECNext Press Release: Daily Market Movers Digest Stock Alerts, Thursday,... - Jun 15, 2006 M2 Presswire; October 23, 1998 ; 700+ words ... ... positive preliminary results of Phase III clinical trial of Nutropin Depot (C ... completion of a ... Pay-Per-View - M2 Presswire - HighBeam Research StreetInsider.com Pre-Open Movers 07/11 - Jul 11, 2007 Nutropin AQ and Increlex were originally designed and formulated so that the therapies could be combined and potentially given as a single, daily injection. ... StreetInsider.com - StreetInsider.com (subscription) Global deals network. - Aug 1, 2007 ...for the development, manufacture, and commercialization of two products containing Genentech's recombinant human growth hormone Nutropin AQ (somatropin, ... Free with registration - Biopharm International - AccessMyLibrary.com Genentech no stranger to San Diego. - Jun 26, 2005 That left Nutropin as the only treatment for dwarfism. ... "The beauty of (Nutropin) is that the purity was as close to 100 percent as humans can get," ... Free with registration - North County Times - AccessMyLibrary.com Tercica Initiates Phase II Clinical Trial with Next-Generation Growth... - Jan 22, 2008 ...two products containing Genentech's recombinant human growth hormone Nutropin AQ(R) and Tercica's recombinant insulin-like growth factor-1 Increlex(R). ... Genetic Engineering News - Genetic Engineering News (press release) Breaking News from Open Energy Corporation (OTCBB: OEGY). - Jun 20, 2007 ...as well as in combination with gemcitabine chemotherapy for the first-line treatment of metastatic pancreatic cancer; and Nutropin and Nutropin AQ ... $4.95 - M2 Presswire - ECNext Are Hopes Getting Too High for Genentech? - May 19, 2008 In addition to the oncology drugs, DNA manufactures heart attack treatment- Activase, Nutropin and Nutropin AQ, growth hormone products, and Pulmozyme, ... Schaeffers Research Press Release: Telcyta was Predicted to Reach the Market by Mid-2007 ... - Apr 18, 2007 M2 Presswire; October 23, 1998 ; 700+ words ... ... positive preliminary results of Phase III clinical trial of Nutropin Depot . ... Pay-Per-View - M2 Presswire - HighBeam Research Tercica begins dosing in Ph II IGF-1 deficiency trial. - Feb 4, 2008 Tercica explained that the new study will compare the Increlex/Nutropin combination's effect on first year high velocity with that of growth hormone alone. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Genentech: in business for life.(Investor Sheet Fact) - Mar 1, 2005 Product development pipeline AS OF JANUARY 10, 2005 AWAITING FDA ACTION NUTROPIN & NUTROPIN AQ IDIOPATHIC SHORT STATURE PHASE III AVASTIN ADJUVANT ... Free with registration - Research - AccessMyLibrary.com Selected biotechnology, biotech-related, small-molecule and other FDA... - Feb 27, 2006 NovoSeven Novo Nordisk (coagulation factor VIIa) Nutropin Genentech, ... episodes in patients with (coagulation factor VIIa) s Nutropin Long-term ... Pay-Per-View - Chain Drug Review - HighBeam Research How far we've come: a Pharm Exec timeline.(Milestones) - Aug 1, 2006 APPROVED: Nutropin Genentech receives approval to begin marketing its second human growth hormone, Nutropin, for the treatment of growth failure in children ... $4.95 - Pharmaceutical Executive - ECNext Factiva Search - Jul 8, 2005 Genentech Stretches Nutropin Markets With New Approvals By Aaron Lorenzo Washington Editor.(Treatment of idiopathic short stature ). 08 July, 2005 ... Pay-Per-View - BIOWORLD Today - Factiva, from Dow Jones Press Release: FVRL, GNVC, HYDG, OESX, OSCI, PHHM Have Also … - Jun 20, 2008 In the Phase III clinical trial, Nutropin Depot was ... month. The Phase III clinical trial was designed to test ... at 27 centers in the United States from ... Pay-Per-View - M2 Presswire - HighBeam Research Alkermes Reports First Quarter Fiscal 2006 Financial Results;... - Aug 4, 2005 ...the same period last fiscal year was primarily the result of the decision by Alkermes and Genentech to discontinue commercialization of Nutropin Depot. ... $4.95 - Business Wire - ECNext Unveiled / Clemens is biggest name on long list of stars alleged to... - Dec 14, 2007 Prescribed for children with growth issues and adults with pituitary gland problems, its brand names include Genotropin, Humatrope and Nutropin. ... Pay-Per-View - Richmond Times - Dispatch - ProQuest Archiver Stocks to Watch: Genentech, Compuware and Ryland - Jul 11, 2007 The two products contain Genentech's recombinant human growth hormone Nutropin AQ and Tercica's recombinant insulin-like growth factor-1 Increlex. ... FOXNews S&P Picks and Pans: Genentech, Infosys, Alcan, Sealy - Jul 11, 2007 The company enters a collaboration agreement with Tercica (TRCA) to develop new growth hormone drugs using Genentech's Nutropin. ... BusinessWeek Wednesday's biggest stock gainers and decliners - MarketWatch - Jul 11, 2007 The two products contain Genentech's recombinant human growth hormone Nutropin AQ and Tercica's recombinant insulin-like growth factor-1 Increlex. ... MarketWatch Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN … - Jan 14, 2008 ...seems to be a general disappointment in one drug or another (Avastin, Rituxan, Herceptin, Lucentis, Xolair, Tarceva, Nutropin, Activase, Raptiva). ... MarketWatch The drugs in question - Dec 14, 2007 Prescribed for children with growth issues and adults with pituitary gland problems. Its brand names include Genotropin, Humatrope, and Nutropin. ... Boston Globe Ros-Lehtinen aide faces insurance fraud charges: A congressional... - Sep 19, 2006 The program paid more than $306000 for 1556 5-milligram vials of Nutropin and 45 10-milligram vials of the medication over a period of five years. ... Free with registration - Miami Herald - AccessMyLibrary.com Drug-tracking delay sought - Mar 25, 2008 That followed recalls of tainted supplies of anemia drugs Procrit and Epogen and growth hormones Nutropin and Serostim. About the same time, worries were ... San Diego Union - Tribune - San Diego Union Tribune Ipsen buys Tercica for $404 million - Jun 5, 2008 Through a deal last summer, Tercica and Genentech are trying to develop a combination of Increlex and Genentech's Nutropin AQ, the leading recombinant human ... Bizjournals.com What price to save a life? - Feb 19, 2006 The company already charges about $70000 for a year's supply of a human growth hormone called Nutropin. A competitor, Genzyme Corp. of Massachusetts, ... Free with registration - Baltimore Sun - AccessMyLibrary.com Parents pay bundle to make small kids taller - Mar 28, 2006 California-based Genentech received similar approval in 2005 for its drug, Nutropin. Technically, it made only children in the lowest 1.2 percentile of the ... San Diego Union - Tribune - San Diego Union Tribune Bad medicine - Jul 2, 2007 So were Procrit (epoetin alfa), marketed by Ortho Biotech Products, of Bridgewater, New Jersey, Nutropin (somatropin), marketed by Genentech of South San ... Nature.com Tercica founder Ross Clark dies - Jun 24, 2008 Tercica and Genentech also announced a deal last summer to develop a combination of Increlex and Genentech's recombinant human growth hormone Nutropin AQ ... Bizjournals.com Divided Congress, complex manufacture challenge biogenerics - Jul.... - Jul 13, 2007 Brozak said the name-brand biotech products facing the most immediate generic threat include Genentech's Nutropin, which will see its patent expire in 2009. ... CNNMoney.com Time for action on fake medicine - Nov 19, 2007 ...made by Serono, and Nutropin, which is sold by Genentech. The cost of these drugs, when genuine, gives an idea of the vast profits the fakers can make. ... The Standard Biotech firms will soon lose patent protection - Sep. 5, 2007 - Sep 5, 2007 Many drugs from the first wave of biotech approvals two decades ago - such as Genentech's human gorwth hormone Nutropin and the company's human insulin ... CNNMoney.com Growth hormones may make children taller, but is it a good idea? - Apr 21, 2006 California-based Genentech received similar approval in 2005 for its drug, Nutropin. "When we talk about children with idiopathic short stature ? we're ... ä¸å›½æ—¥æŠ¥ - ä¸å›½æ—¥æŠ¥ Ros-Lehtinen aide faces health insurance charges. - Sep 18, 2006 Ileana Ros-Lehtinen turned himself in to federal authorities today to face charges he filed false insurance claims for the human growth hormone Nutropin. ... Free with registration - Miami Herald - AccessMyLibrary.com Features | PE.com | Southern California News | News for Inland... - Mar 23, 2006 California-based Genentech received similar approval in 2005 for its drug, Nutropin. "When we talk about children with idiopathic short stature ... we're ... Press-Enterprise Management of growth retardation in pediatric recipients of renal … - Dec 15, 2006 A 2-year RCT of the use of rhGH in growth-retarded children with CKD led the FDA to approve rhGH (Nutropin ® ; Genentech, South San Francisco, ... Nature.com More parents willing to pay thousands of dollars to increase their... - Apr 11, 2006 California-based Genentech received similar approval in 2005 for its drug, Nutropin. "When we talk about children with Idiopathic Short Stature . . . we're ... $2.95 - Buffalo News - NewsBank Gain an inch, pay a bundle Use of growth therapy rising despite price... - Mar 13, 2006 California-based Genentech received similar approval in 2005 for its drug, Nutropin. Technically, it made only children in the lowest 1.2 percentile of the ... $2.95 - Kansas City Star - NewsBank THE DRUGS - Dec 14, 2007 Examples: Nutropin, Genotropin. Benefits: Secreted by the pituitary gland, HGH stimulates growth and cell reproduction, which in athletes often translates ... Pay-Per-View - San Diego Union - Tribune - ProQuest Archiver Orphan drugs moving ahead ; Focus: Their development is a fast... - Aug 28, 2005 California-based Genentech Inc. charges about $70000 per year per patient for the human growth hormone called Nutropin. Insurance companies tend to cover ... Pay-Per-View - The Sun - ProQuest Archiver More parents willing to pay thousands to give short kids a boost - Mar 22, 2006 California-based Genentech received similar approval in 2005 for its drug, Nutropin. Technically, it made only children in the lowest 1.2 percentile of the ... Times Herald-Record The pituitary gland: Tiny control center - Dec 31, 2006 Today, Genentech sells other versions of rHGH under the Nutropin name. A controversial use of such therapy is to increase the height of children who would ... North County Times Buying drugs online? Be aware of serious risks - Feb 5, 2008 Besides Lipitor, counterfeit products included Combivir, Epogen, Gamimune, Neupogen, Nutropin AQ, Serostim, Procrit, Viagra and Zyprexa. ... $2.95 - Lexington Herald Leader - NewsBank 美股评论：并è´é£Žæ½®å¸å?·ç”Ÿç‰©åˆ¶è?¯ä¸š - Aug 22, 2008 ...对罗æ°?而言，Genentech包括心è„?ç—…è?¯å“?Activaseã€?抗癌è?¯Avastinå’Œç”Ÿé•¿æ¿€ç´ äº§å“?Nutropin 在内的众多产å“?都是å?¸å¼•åŠ›æ‰€åœ¨ã€‚ æ¿€å?‘大型制è?¯å…¬å?¸å¯¹æ–°äº§å“?éœ€æ±‚çš„å› ç´ æ˜¯å‡ ç§?é‡?è¦? ... 新浪网 San Diego Business Journal Online - business news for San Diego, … - Jun 25, 2007 While the likelihood that Amylin's Byetta will be “genericizedâ€? by 2015 is “moderate,â€? the risk for Genentech's Nutropin and Protropin is “high,â€? the report ... San Diego Business Journal - San Diego Business Journal Biotech News: In Depth Research on Genentech Inc. - Mar 23, 2007 Genentech's other marketed drugs include cardiovascular therapies Activase and TNKase, human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Ipsen and Tercica to Enter into Worldwide Strategic Collaboration in ... - Jul 19, 2006 Ibsen is Genentech's European partner for the Nutropin AQ brand of growth hormone. Third, each company will grant to the other certain joint development and ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Investor Alert for Genentech Inc. - Feb 22, 2007 The biotech also makes cardiovascular therapies Activase and TNKase, human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair, ... $4.95 - M2 Presswire - ECNext Daily Market Alert for Genentech Inc. - Nov 17, 2006 The biotech also makes cardiovascular therapies Activase and TNKase, human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair, ... Free with registration - M2 Presswire - AccessMyLibrary.com A biogeneric company leads the field of next generation human growth ... - Oct 24, 2005 After Genentech had to terminate commercialisation of its Nutropin Depot preparation, the field now is lead by Korea-based LG Life Science and its European ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Altus Pharmaceuticals Presents Positive Data From Phase I Study of … - Sep 28, 2005 ...injection of ALTU-238 were comparable to those achieved in subjects receiving the same amount of growth hormone with 7 daily injections of Nutropin AQ. ... RedOrbit More In Features - Jul 1, 2007 Wins included Genentech brands Nutropin and Pulmozyme; a yet-to-be-launched pain drug from Abbott Laboratories; Sirion Therapeutics; Janumet (global) for ... Medical Marketing & Media - Medical Marketing and Media Alkermes Reports Third Quarter Fiscal 2005 Financial Results. - Feb 3, 2005 ...consisting of approximately $2.7 million for Risperdal Consta and $1.4 million for Nutropin Depot(R). The increase in cost of goods manufactured for the ... Free with registration - Business Wire - AccessMyLibrary.com pharmaceutical coverage by SFist - Jul 21, 2008 ...makers of some of the world's most boring prescription drugs ever (eg, supplementary growth hormones Protropin and Nutropin, clot-busting pill TNKase, ... SFist Growth Is in Its DNA - Nov 14, 2005 Cathflo to open blood clots in central vein access devices; the Nutropin Pen, which provides adjustable dosing for human growth hormone to kids with ... Smartmoney.com Big shot developments in prefilled syringes: many companies are... - Mar 1, 2007 Berlex's (Wayne, NJ) "Betaseron" multiple sclerosis treatment, and the human growth hormones "Norditropin" (Novo Nordisk, Princeton, NJ), and "Nutropin" ... Free with registration - Pharmaceutical Technology - AccessMyLibrary.com Event Brief of Q3 2007 Genentech, Inc. Earnings Conference Call -... - Oct 15, 2007 US sales for Nutropin were $93m in 3Q07, a 1% increase over 3Q06. 2. US sales for Lytics were $67m, 12% increase over 3Q06. 3. US sales for Pulmozyme were ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com In business for life - May 30, 2005 1993 - Nutropin® (recombinant somatropin) - Growth hormone for children and adults for treatment before kidney transplant due to chronic renal insufficiency ... chemie.de Russell 2000 unchanged - Jul 11, 2007 Tercica is developing an injectable treatment that combines its drug Increlex with Genentech's growth hormone Nutropin for kids, the Brisbane, Calif. ... SmallCapInvestor Introducing the Brand New Report on Business Strategies for Different... - Dec 6, 2007 Mircera - NeoRecormon - Neulasta - Neulasta/Neupopeg - Neupogen - Norditropin - Novolin N - NovoLog/NovoRapid - Novolon - Nutropin - Omnitrope - Pegasys ... Free with registration - Business Wire - AccessMyLibrary.com Wrong way to fight counterfeit drugs | drug, counterfeit, drugs, law,... - Jul 11, 2008 Also in 2003, the FDA issued anti-counterfeit recalls for two popular growth hormones, Nutropin and Serostim. And our in-boxes are flooded daily with ... OCRegister Small-cap biopharmaceutical stocks: worth a look in 2007: while small... - Aug 1, 2007 ...to combine its Increlex with Genentech's Nutropin, a growth hormone, to form a once-daily injectable treatment for children who don't grow normally. ... Free with registration - Biopharm International - AccessMyLibrary.com ePt@PharmTech.com.(IN THE FIELD: MONTH IN REVIEW)(briefs)( … - Sep 1, 2007 ...manufacture, and worldwide commercialization of two products containing Genentech's recombinant human-growth hormone "Nutropin AQ" (somatropin (rDNA ... Free with registration - Pharmaceutical Technology - AccessMyLibrary.com Brand Names/Synonyms: Nutropin is also known by the following brand names and/or synonymsSomatotropin precursor;Growth hormone;GH;GH-N;Pituitary growth hormone;Growth hormone 1; BioTropin (Biotech General); Genotropin (Pharmacia; Pfizer); Humatrope (Eli Lilly); Tev-Tropin (GATE); Nutropin (Genentech Inc.); NutropinAQ (Genentech Inc.); Protropin (Genentech Inc.); Norditropin (Novo Nordisk); Saizen (Serono SA); Serostim (Serono SA) Drug Category: Nutropin is categorized under the following by the FDA: Anabolic Agents; Hormone replacement; pituitary (68:28.00) Dosage Forms: LIQUID;POWDER FOR SOLUTION Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Human growth hormone |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |